Last reviewed · How we verify
Polyene Phosphatidyl choline
Polyene Phosphatidyl choline is a Small molecule drug developed by Zhejiang Hisun Pharmaceutical Co. Ltd.. It is currently FDA-approved. Also known as: Polyene Phosphatidyl choline for 6 weeks, Yi Shan Fu.
Polyene phosphatidylcholine is a treatment option studied for various liver conditions, including drug-induced acute liver injury, acute liver failure, and hepatitis, among others. It is administered in capsule form, with a dosage of 228mg per particle.
At a glance
| Generic name | Polyene Phosphatidyl choline |
|---|---|
| Also known as | Polyene Phosphatidyl choline for 6 weeks, Yi Shan Fu |
| Sponsor | Zhejiang Hisun Pharmaceutical Co. Ltd. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Real World Study of Polyene Phosphatidylcholine Injection for the Prevention and Treatment of DILI in Patients With Malignant Hematological Diseases
- Evaluate Pharmacokinetic/Pharmacodynamic and Safety/Tolerability of AYP-101 in Healthy Subjects (PHASE1)
- Evaluate the Efficacy and Safety of AYP-101 for the Reduction of Submental Fat in Chin Area (PHASE3)
- A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus (PHASE2)
- Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia (NA)
- F573 for Injection for the Treatment of Liver Injury/Failure (PHASE2)
- The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine (PHASE4)
- Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Polyene Phosphatidyl choline CI brief — competitive landscape report
- Polyene Phosphatidyl choline updates RSS · CI watch RSS
- Zhejiang Hisun Pharmaceutical Co. Ltd. portfolio CI
Frequently asked questions about Polyene Phosphatidyl choline
What is Polyene Phosphatidyl choline?
Who makes Polyene Phosphatidyl choline?
Is Polyene Phosphatidyl choline also known as anything else?
What development phase is Polyene Phosphatidyl choline in?
Related
- Manufacturer: Zhejiang Hisun Pharmaceutical Co. Ltd. — full pipeline
- Also known as: Polyene Phosphatidyl choline for 6 weeks, Yi Shan Fu
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing